Christopher Brittain

Christopher Brittain

Company: Genentech

Job title: Vice President & Global Head of Ophthalmology Product Development


Topics to be discussed: 9:15 am

• Understanding the continuum of care for preventing, slowing, or reversing dry AMD at various stages of the disease – where do pharmacological, cell therapies, gene therapy approaches, light therapies and vision prosthesis play a role in the patient’s therapeutic journey? • Discussing the potential for sequential or combination regimens depending on stage of disease…Read more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.